Revanesse® is a remarkably homogeneous filler due to our advanced technology and proprietary formula. This means that our particles are uniquely spherical and uniform, providing the perfect balance between smoothness and volume.


The spherical particle shape of Revanesse® is developed to be accepted by the body and break down slowly over time.


In a clinical study, the incidence of swelling was 51% higher with the comparator.*


Revanesse® is the only line of cross-linked HA dermal fillers that is made in Canada. Our manufacturing facility is located just north of Toronto, Ontario, Canada. Prollenium Medical Technologies Inc. is an ISO registered company, meets or exceeds all Health Canada regulations, and is among a select few dermal filler companies to receive FDA approval within the United States.
*Injection site swelling (47.2% [77/163] with Revanesse®, 71.2% [116/163] with Comparator). Revanesse® is a registered trademark of Prollenium Medical Technologies Inc.

Swelling: Swelling is also expected and may take several days to a week to resolve. While swelling is unusual, medical treatment may be necessary if swelling is slow to resolve. Pain: Some discomfort is expected with injections but usually lasts less than a day. For additional risks, please talk to your healthcare provider.